/ /

Mark B. Abelson, MD
What clinicians should know about ocular allergies
What clinicians should know about ocular allergies
The arrival of spring also signals the onset of ocular allergy season. Clinicians can prepare by knowing and recognizing the symptoms in their patients, as well as being informed about the latest therapies for this diagnosis.
Questions remain regarding antibacterial therapy
Times have changed, and, with them, practices in antibacterial therapy. Questions remain, however. Has progress been made over the decades, and what does the future hold?
Innovation takes center stage at Association for Research in Vision and Ophthalmology 2008 meeting
The focus was on innovation at this year's annual meeting of the Association for Research in Vision and Ophthalmology. Among the highlights were the latest developments in the areas of retinal disease, allergy, dry eye, and lid margin disease.
Oral treatment options abound for dry eye
The eyes can be affected by over-the-counter (OTC) systemic medications, nutrition habits, and systemic agents—all of which contribute to dry eye. Oral treatment options should be considered in these cases, whereas topical treatment with artificial tears is the best option for external causes.
Aging eye is focus of ARVO meeting in 2007
This year, the Association for Research in Vision and Ophthalmology annual meeting focused on the aging eye. With reference to new treatment possibilities, researchers presented information about novel therapies for age-related macular degeneration, glaucoma, and other age-associated ocular conditions, as well as investigations of current treatments.
The ophthalmic pharmaceutical pipeline expands
The use of hormonal therapies may represent the next generation of medication for the tear film deficiencies of dry eye.

Poll

View Results